This week, the U.S. Food and Drug Administration granted researchers permission to move forward with a study plan for a large-scale phase three clinical trial studying the effects of MDMA as a therapeutic drug for post-traumatic stress disorder. The news comes after the FDA reviewed the results of a years-long phase two
This article originally appeared on www.rollingstone.com: How MDMA Treats PTSD: Everything You Need to Know
from Rolling Stone Latest Sports and Music and Movies and Politics and Culture News http://www.rollingstone.com/culture/news/how-mdma-treats-ptsd-everything-you-need-to-know-w453273
No comments:
Post a Comment